Aptargroup Inc

ATRNYSE · USD
140.08USD0.00 (-0.19%)
799

Aptargroup Inc (ATR) Covered Calls

Aptargroup Inc trades in the Medical Instruments & Supplies industry with an IV Rank of 25.00%, low versus the past year. ATR's highest covered call setup is the $145.00 strike expiring Dec 18, 2026, sorted by theoretical annualized return. It's 3.32% out of the money with 29 days to expiration, a 3.93% return until expiration, and a 49.42% theoretical annualized return. Across the setups shown, annualized returns run from 26.38% to 49.42% at strikes between $145.00 and $175.00, with 29 to 183 days to expiration, as of Nov 19, 2026.

Read more

Running ATR covered calls helps you generate income from Aptargroup Inc shares you already own, turning a long stock position into a yield producing asset. A covered call means holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike. Use our scanner to find the best ATR covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call pairs limited risk with a clear income profile. If ATR stays below the strike at expiration, you keep the premium and the shares. If it rises above, you deliver the stock at the strike and still pocket the premium. Selling ATR covered calls works best when implied volatility is elevated, since richer premiums improve the risk reward. Key inputs include strike selection relative to delta, days to expiration, annualized return, and probability of assignment, all of which determine whether a given ATR covered call is worth writing.

AptarGroup, Inc. provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases in pharmaceutical market; elastomer for injectable primary packaging components; and active material science solutions.

2026-12-1829145.003.320.853.90551.003.9349.42-0.61+0.3633.05
2027-05-21183175.0024.700.103.703476.0024.7749.40-0.07+0.1623.60
2027-01-1557150.006.880.154.40981.006.9944.76-0.11+0.2804.25
2027-02-1992155.0010.450.604.201526.0010.8743.14-0.43+0.2503.60
2027-05-21183170.0021.130.654.103031.0021.6043.08-0.46+0.1913.45
2027-05-21183165.0017.571.404.702606.0018.5737.04-1.00+0.2303.30
2027-02-1992150.006.881.855.401151.008.2032.54-1.32+0.3453.55
2027-05-21183160.0014.012.105.702176.0015.5130.93-1.50+0.2903.60
2027-01-1557145.003.321.805.20646.004.6029.48-1.28+0.4003.40
2027-05-21183155.0010.453.906.801856.0013.2326.38-2.78+0.3632.90

As of Nov 19, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →

Stock Statistics

  • IndustryMedical Instruments & Supplies
  • SectorHealthcare
  • IV Rank25.00% Low
  • Market cap (M$)8,880
  • 52 weeks high-5.75%
  • 52 weeks low26.26%
  • Analyst recommendationBuy
    1.83
  • Target price$163.86
    16.98% above the current stock price
  • Dividend—
  • Payout ratio31.11%
  • Earnings date2027-02-04
  • P/E33.98
  • Future P/E22.59
  • EPS (ttm)4.12
  • EPS growth next 5 years6.15%

As of Nov 19, 2026